REFERENCES
- Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. American Diabetes Association: Retinopathy in diabetes. Diabetes Care 2004;27(Suppl 1):S84–7.
- Yamada M, Hirtsuka Y, Roberts CB, Pezzullo ML, Takano S, Miyake K, Taylor HR. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol. 2010;17:50–57.
- Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: An extension of the modified Airlie House classification: ETDRS report number 10. Ophthalmology 1991;98(5 Suppl):786–806.
- Cheung N, Mitchell A, Wong TY. Diabetic retinopathy. Lancet 2010;376:124–136.
- Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002;13(5–6):301–6.
- Martin JF, Trowbridge E.A, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, platelet thromboxan B2 production and megakaryocyte nuclear DNA concentration. Thrombosis 1983;32:443–460.
- Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: An Indian scenario. J Clin Pathol 2006;59:146–149.
- Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004;35:1688–91.
- Jurcut R, Arsenescu I, Puscariu T, Uscatescu V, Jurcut C, Apetrei E, Ginghina C. Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina? Rom J Intern Med. 2005;43(3–4):199–209.
- Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007;357:2482–2494.
- Citirik M, Beyazyildiz E, Sımsek M, Beyazyildiz O, Haznedaroğlu IC. MPV may reflect subclinical platelet activation in diabetic patients with and without diabetic retinopathy. Eye (Lond). 2015;29(3):376–9.
- Roggeri ZM. Platelets in atherothrombosis. Nat Med 2002;8:1227–34.
- Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378–84.
- Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabets Care 2001;24:1476–1485.
- Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas T. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004;15:475–478.
- Tuzcu AE, Arıca S, Ilhan N, Daglıoglu M, Coşkun M, Ilhan O, Ustun I. Relationship between mean platelet volume and retinopathy in patients with type 2 diabets mellitus. Graefes Arch Clin Exp Ophthalmol 2014;252:237–240.
- Jindal S, Gupta R, Gupta R, Kakkar A, Singh HV, Gupta K, Singh S. Platelet indices in diabetes mellitus: Indicators of diabetic microvascular complication. Hematology 2011;16:86–89.
- Chen E, Looman M, Laouri M, Gallagher M, Van Nuys K, Lakdawalla D, Fortuny J. Burden of illness of diabetic macular edema: Literature review. Curr Med Res Opin. 2010;26:1587–97.
- Klaassen I, Van Noorden CJ, Schlingemann RO. Molecular basis of the inner blood retinal barrier and its breakdown in diabetic macular edema and other pathological condition. Prog Retina Eye Res. 2013;34:19–48.